Literature DB >> 7230285

Experimental and clinical experiences with collagen fleece as a hemostatic agent.

M E Silverstein, M Chvapil.   

Abstract

We report on our laboratory and clinical experience with a new hemostatic agent made of collagen fibers and existing in the form of a loose or compressed fleece. This material was tested in two independent bleeding models on eight dogs and 21 patients. Partially compressed collagen fleece showed significantly higher hemostatic effectiveness when compared to loose fleece. This was demonstrated by gravimetric determinations of blood loss in dogs with split-thickness skin excisions and by measuring the blood loss and time of bleeding after an excision 0.5 cm deep and 4 cm wide of the edge of the spleen. The handling of partially compressed hemostatic fleece was found superior to loose or fully compressed fleece. Clinical cases included patients with liver lacerations and retroperitoneal bleeding. Collagen fleece, partially compressed, proved to be an effective topical hemostatic agent when applied directly with pressure to a bleeding surface and when folded and sutured against a bleeding surface. Postoperative injection rate was not increased nor was foreign body reaction demonstrated. The material was extremely easy to apply, did not adhere to gloves or instruments, and could be cut or molded to any desired shape.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7230285     DOI: 10.1097/00005373-198105000-00011

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

Review 1.  The use of local agents: bone wax, gelatin, collagen, oxidized cellulose.

Authors:  Claudio Schonauer; Enrico Tessitore; Giuseppe Barbagallo; Vincenzo Albanese; Aldo Moraci
Journal:  Eur Spine J       Date:  2004-06-22       Impact factor: 3.134

2.  The use of a biodegradable collagen/vicryl composite membrane to repair partial nephrectomy in rabbits.

Authors:  R Mohammed; M J Monsour; S D Gorham; D A French; R Scott
Journal:  Urol Res       Date:  1987

3.  Experience from the use of absorbable type I collagen as haemostatic agent in obstetric and gynecological operations.

Authors:  V Karagiannis; A Daniilidis; D Rousso; V Palapelas; T Karagiannis; D Kiskinis
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

Review 4.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

5.  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial.

Authors:  Petra Baumann; Hardy Schumacher; Johannes Hüsing; Steffen Luntz; Hanns-Peter Knaebel
Journal:  Trials       Date:  2009-09-29       Impact factor: 2.279

6.  Achieving hemostasis in dermatology-Part II: Topical hemostatic agents.

Authors:  Jaimie B Glick; Ravneet R Kaur; Daniel Siegel
Journal:  Indian Dermatol Online J       Date:  2013-07

Review 7.  The Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A Review.

Authors:  Saeed Nouri; Mohammad Reza Sharif; Hasan Afzali; Alireza Sharif; Mojtaba Satkin
Journal:  Trauma Mon       Date:  2015-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.